At the end of 2022, it concluded its Series C funding round, netting the company an additional £40.4 million.

Source: https://www.forres-gazette.co.uk/news/satellite-firm-does-euro-deal-318680/

Deerfield Management Company L.P. Series C now owns 2,012,714 shares of the company’s stock worth $196,199,000 after buying an additional 354,914 shares during the period.

Source: https://www.etfdailynews.com/2023/01/09/achmea-investment-management-b-v-increases-stock-holdings-in-neurocrine-biosciences-inc-nasdaqnbix/

Finally, Deerfield Management Company L.P. Series C bought a new position in shares of Amedisys in the second quarter valued at $20,919,000.

Source: https://www.etfdailynews.com/2023/02/13/amedisys-inc-nasdaqamed-shares-sold-by-new-york-state-common-retirement-fund/

The company, which last raised 2.58 billion yen in a Series C round in 2021, has brought in 14.3 billion yen since its founding in 2008.

Source: https://spacenews.com/axelspace-raises-44-million-for-earth-observation-and-other-smallsats/

This year, Treasury Prime secured $40 million in Series C funding and Synctera raised $15 million to launch embedded products in Canada.

Source: https://techcrunch.com/2023/08/11/fintech-banking-as-a-service-outlier/